L.J. Altfest & Co’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2,351
| Closed | -$286K | – | 359 |
|
2024
Q4 | $286K | Buy |
+2,351
| New | +$286K | 0.04% | 275 |
|
2024
Q3 | – | Sell |
-1,931
| Closed | -$305K | – | 367 |
|
2024
Q2 | $305K | Sell |
1,931
-760
| -28% | -$120K | 0.04% | 254 |
|
2024
Q1 | $348K | Buy |
+2,691
| New | +$348K | 0.05% | 237 |
|
2021
Q4 | – | Sell |
-3,760
| Closed | -$348K | – | 269 |
|
2021
Q3 | $348K | Buy |
3,760
+29
| +0.8% | +$2.68K | 0.07% | 183 |
|
2021
Q2 | $290K | Buy |
3,731
+22
| +0.6% | +$1.71K | 0.06% | 212 |
|
2021
Q1 | $276K | Buy |
3,709
+926
| +33% | +$68.9K | 0.07% | 215 |
|
2020
Q4 | $474K | Buy |
2,783
+815
| +41% | +$139K | 0.12% | 133 |
|
2020
Q3 | $276K | Buy |
+1,968
| New | +$276K | 0.07% | 180 |
|
2020
Q1 | – | Sell |
-1,629
| Closed | -$210K | – | 225 |
|
2019
Q4 | $210K | Buy |
+1,629
| New | +$210K | 0.05% | 184 |
|